liposomal cytarabine

DRUG10 trials

Sponsors

National Cancer Institute (NCI), Pacira Pharmaceuticals, Inc, Beth Israel Deaconess Medical Center, AIDS Malignancy Consortium, Nordic Society for Pediatric Hematology and Oncology

Conditions

Acute Lymphoblastic LeukemiaBrain and Central Nervous System TumorsBreast CancerCentral Nervous System MetastasesLeptomeningeal MetastasesLeptomeningeal Metastasis From Malignant MelanomaLeukemiaLymphoma

Phase 1

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Pacira Pharmaceuticals, IncBrain and Central Nervous System Tumors, Leukemia, Lymphoma +1

Start: 1997-02-28Target: 15Updated: 2010-03-23

A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain

TerminatedNCT01563614

University Hospital, BonnLeptomeningeal Metastasis From Malignant Melanoma

Start: 2012-03-31End: 2015-11-30Updated: 2016-04-19

Phase 2

Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma

CompletedNCT00073957

Beth Israel Deaconess Medical CenterLymphoma

Start: 2003-12-31End: 2012-01-01Updated: 2018-01-23

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

CompletedNCT00002704

National Cancer Institute (NCI)Leukemia

Start: 1996-01-31Updated: 2013-02-01

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

CompletedNCT00392834

AIDS Malignancy ConsortiumLymphoma

Start: 2006-09-30End: 2013-07-31Updated: 2018-06-06

Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer

CompletedNCT00992602

University of WashingtonCentral Nervous System Metastases, Leptomeningeal Metastases, Recurrent Breast Cancer +2

Start: 2011-04-30End: 2014-10-31Updated: 2017-07-07

CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis

CompletedNCT01325194

Nordic Lymphoma GroupPrimary Disease

Start: 2011-03-31End: 2019-12-31Updated: 2020-03-03

Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children

National Cancer Institute, NaplesAcute Lymphoblastic Leukemia

Start: 2012-03-31End: 2024-12-31Target: 31Updated: 2023-03-24

Phase 3

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

SuspendedNCT00991744

Nordic Society for Pediatric Hematology and OncologyAcute Lymphoblastic Leukemia

Start: 2009-01-31End: 2018-12-31Target: 100Updated: 2012-10-10

Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer

CompletedNCT01645839

Centre Oscar LambretBreast Cancer, Leptomeningeal Metastases

Start: 2011-08-30End: 2019-03-01Updated: 2019-06-12

Related Papers

Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.

2024-04-041 citations

Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma

eJHaem2022-06-238 citations

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma.

2021-03-01114 citations

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Blood Advances2020-05-0753 citations

Genomic Profiling of Circulating Tumor DNA Reveals Patterns of Response and Refractoriness in Aggressive B-Cell Lymphoma - a Nordic Lymphoma Group Correlative Study

Blood2019-11-131 citations

Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer

Neuro-Oncology2019-10-17101 citations

CMET-39. INTRA-CSF LIPOSOMAL CYTARABINE PLUS SYSTEMIC THERAPY AS INITIAL TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS: A RANDOMISED, OPEN-LABEL TRIAL

Neuro-Oncology2018-11-012 citations

Intra-CSF liposomal cytarabine plus systemic therapy as initial treatment of breast cancer leptomeningeal metastasis: A randomised, open-label trial

Annals of Oncology2018-10-016 citations

BMET-25RESULTS OF THE INTERIM SAFETY ANALYSIS OF THE DEPOSEIN TRIAL IN LEPTOMENINGEAL METASTASES FROM BREAST CANCER

Neuro-Oncology2015-11-011 citations

AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma

Blood2015-05-0898 citations

Dose-Dense Chemoimmunotherapy and Early Central Nervous System Prophylaxis For High-Risk Diffuse Large B-Cell Lymphoma. –Preliminary Results From a Nordic Phase II Study

Blood2013-11-152 citations